Orthovita, Inc.
U.S. FDA approves further changes to CORTOSS IDE pivotal study protocol
Published in Lab Business Week, May 21st, 2006
The changes include a reduction in the number of total patients to be enrolled from 300 down to 243, as well as an increase in the randomization ratio of patients treated with CORTOSS to patients in the control group treated with an approved PMMA bone cement. The protocol now provides for the enrollment of 162 patients in the CORTOSS arm of the study and 81 patients in the control group, for an overall randomization of 2:1.
The prospective randomized...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2006-05-21)
More Articles from Lab Business Week
- Acadia Pharmaceuticals, Inc.
Acadia announces proposed public stock offering - Aida Pharmaceuticals, Inc.
Aida Pharmaceuticals reports 56.8% increase in revenue - Biomerica, Inc.
Biomerica reports diagnostics sales of almost $1M - Bradmer Pharmaceuticals, Inc.
Bradmer commences trading on Toronto Stock Exchange - China Biopharmaceuticals Holdings, Inc.
China Biopharmaceuticals Holdings records 280% increase in revenue - Dynavax Technologies Corporation
Dynavax to advance cancer, hepatitis B, and hepatitis C therapy with $50 million funding - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
